Electrical Equipment & Parts
Compare Stocks
5 / 10Stock Comparison
AYI vs ETN vs HUBB vs NVT vs EMR
Revenue, margins, valuation, and 5-year total return — side by side.
Industrial - Machinery
Electrical Equipment & Parts
Electrical Equipment & Parts
Industrial - Machinery
AYI vs ETN vs HUBB vs NVT vs EMR — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Electrical Equipment & Parts | Industrial - Machinery | Electrical Equipment & Parts | Electrical Equipment & Parts | Industrial - Machinery |
| Market Cap | $9.06B | $155.02B | $26.21B | $26.96B | $79.02B |
| Revenue (TTM) | $4.54B | $28.52B | $6.00B | $4.33B | $18.32B |
| Net Income (TTM) | $410M | $3.99B | $906M | $492M | $2.44B |
| Gross Margin | 48.1% | 36.9% | 35.5% | 37.0% | 52.7% |
| Operating Margin | 13.0% | 18.1% | 20.8% | 15.8% | 19.8% |
| Forward P/E | 15.0x | 30.1x | 24.9x | 37.2x | 21.7x |
| Total Debt | $1.00B | $11.17B | $2.61B | $1.56B | $13.76B |
| Cash & Equiv. | $423M | $622M | $483M | $238M | $1.54B |
AYI vs ETN vs HUBB vs NVT vs EMR — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Acuity Brands, Inc. (AYI) | 100 | 340.5 | +240.5% |
| Eaton Corporation p… (ETN) | 100 | 472.9 | +372.9% |
| Hubbell Incorporated (HUBB) | 100 | 402.4 | +302.4% |
| nVent Electric plc (NVT) | 100 | 927.2 | +827.2% |
| Emerson Electric Co. (EMR) | 100 | 231.5 | +131.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: AYI vs ETN vs HUBB vs NVT vs EMR
Each card shows where this stock fits in a portfolio — not just who wins on paper.
AYI ranks third and is worth considering specifically for sleep-well-at-night and valuation efficiency.
- Lower volatility, beta 1.40, Low D/E 36.9%, current ratio 1.95x
- PEG 1.01 vs EMR's 4.80
- Lower P/E (15.0x vs 21.7x), PEG 1.01 vs 4.80
ETN is the clearest fit if your priority is long-term compounding.
- 6.1% 10Y total return vs NVT's 5.8%
HUBB carries the broadest edge in this set and is the clearest fit for defensive.
- Beta 1.38, yield 1.1%, current ratio 1.72x
- 15.1% margin vs AYI's 9.0%
- Beta 1.38 vs NVT's 1.68
- 11.6% ROA vs EMR's 5.8%, ROIC 17.1% vs 8.2%
NVT is the #2 pick in this set and the best alternative if growth exposure is your priority.
- Rev growth 29.5%, EPS growth 118.8%, 3Y rev CAGR 19.3%
- 29.5% revenue growth vs EMR's 3.0%
- +178.6% vs AYI's +17.9%
EMR is the clearest fit if your priority is income & stability.
- Dividend streak 37 yrs, beta 1.52, yield 1.5%
- 1.5% yield, 37-year raise streak, vs HUBB's 1.1%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 29.5% revenue growth vs EMR's 3.0% | |
| Value | Lower P/E (15.0x vs 21.7x), PEG 1.01 vs 4.80 | |
| Quality / Margins | 15.1% margin vs AYI's 9.0% | |
| Stability / Safety | Beta 1.38 vs NVT's 1.68 | |
| Dividends | 1.5% yield, 37-year raise streak, vs HUBB's 1.1% | |
| Momentum (1Y) | +178.6% vs AYI's +17.9% | |
| Efficiency (ROA) | 11.6% ROA vs EMR's 5.8%, ROIC 17.1% vs 8.2% |
AYI vs ETN vs HUBB vs NVT vs EMR — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
AYI vs ETN vs HUBB vs NVT vs EMR — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
EMR leads in 2 of 6 categories
AYI leads 1 • HUBB leads 1 • NVT leads 1 • ETN leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
EMR leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ETN is the larger business by revenue, generating $28.5B annually — 6.6x NVT's $4.3B. HUBB is the more profitable business, keeping 15.1% of every revenue dollar as net income compared to AYI's 9.0%. On growth, NVT holds the edge at +53.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $4.5B | $28.5B | $6.0B | $4.3B | $18.3B |
| EBITDAEarnings before interest/tax | $711M | $5.9B | $1.5B | $848M | $4.7B |
| Net IncomeAfter-tax profit | $410M | $4.0B | $906M | $492M | $2.4B |
| Free Cash FlowCash after capex | $535M | $4.7B | $909M | $387M | $3.1B |
| Gross MarginGross profit ÷ Revenue | +48.1% | +36.9% | +35.5% | +37.0% | +52.7% |
| Operating MarginEBIT ÷ Revenue | +13.0% | +18.1% | +20.8% | +15.8% | +19.8% |
| Net MarginNet income ÷ Revenue | +9.0% | +14.0% | +15.1% | +11.4% | +13.3% |
| FCF MarginFCF ÷ Revenue | +11.8% | +16.5% | +15.2% | +8.9% | +17.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | +20.2% | +16.8% | +11.1% | +53.5% | +2.9% |
| EPS Growth (YoY)Latest quarter vs prior year | +13.7% | -9.4% | +8.3% | -59.7% | +28.2% |
Valuation Metrics
AYI leads this category, winning 6 of 7 comparable metrics.
Valuation Metrics
At 23.6x trailing earnings, AYI trades at a 39% valuation discount to NVT's 38.7x P/E. Adjusting for growth (PEG ratio), HUBB offers better value at 1.43x vs EMR's 7.73x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $9.1B | $155.0B | $26.2B | $27.0B | $79.0B |
| Enterprise ValueMkt cap + debt − cash | $9.6B | $165.6B | $28.3B | $28.3B | $91.2B |
| Trailing P/EPrice ÷ TTM EPS | 23.58x | 38.17x | 29.81x | 38.68x | 34.92x |
| Forward P/EPrice ÷ next-FY EPS est. | 14.99x | 30.11x | 24.95x | 37.22x | 21.70x |
| PEG RatioP/E ÷ EPS growth rate | 1.59x | 1.55x | 1.43x | — | 7.73x |
| EV / EBITDAEnterprise value multiple | 13.27x | 27.69x | 20.81x | 34.30x | 18.07x |
| Price / SalesMarket cap ÷ Revenue | 2.08x | 5.65x | 4.48x | 6.93x | 4.39x |
| Price / BookPrice ÷ Book value/share | 3.43x | 7.99x | 6.85x | 7.36x | 3.94x |
| Price / FCFMarket cap ÷ FCF | 17.00x | 34.67x | 29.97x | 72.49x | 29.63x |
Profitability & Efficiency
HUBB leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
HUBB delivers a 24.4% return on equity — every $100 of shareholder capital generates $24 in annual profit, vs $12 for EMR. AYI carries lower financial leverage with a 0.37x debt-to-equity ratio, signaling a more conservative balance sheet compared to EMR's 0.68x. On the Piotroski fundamental quality scale (0–9), HUBB scores 7/9 vs AYI's 4/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +14.7% | +20.8% | +24.4% | +13.4% | +12.1% |
| ROA (TTM)Return on assets | +8.8% | +9.0% | +11.6% | +7.2% | +5.8% |
| ROICReturn on invested capital | +16.4% | +13.6% | +17.1% | +8.9% | +8.2% |
| ROCEReturn on capital employed | +16.9% | +16.8% | +20.1% | +10.5% | +10.0% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 6 | 7 | 6 | 7 |
| Debt / EquityFinancial leverage | 0.37x | 0.57x | 0.68x | 0.42x | 0.68x |
| Net DebtTotal debt minus cash | $582M | $10.5B | $2.1B | $1.3B | $12.2B |
| Cash & Equiv.Liquid assets | $423M | $622M | $483M | $238M | $1.5B |
| Total DebtShort + long-term debt | $1.0B | $11.2B | $2.6B | $1.6B | $13.8B |
| Interest CoverageEBIT ÷ Interest expense | 11.88x | 16.38x | 16.90x | 6.61x | 6.46x |
Total Returns (Dividends Reinvested)
NVT leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in NVT five years ago would be worth $53,671 today (with dividends reinvested), compared to $15,571 for AYI. Over the past 12 months, NVT leads with a +178.6% total return vs AYI's +17.9%. The 3-year compound annual growth rate (CAGR) favors NVT at 59.8% vs EMR's 20.7% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -20.8% | +22.3% | +6.8% | +56.5% | +4.3% |
| 1-Year ReturnPast 12 months | +17.9% | +33.2% | +41.5% | +178.6% | +30.4% |
| 3-Year ReturnCumulative with dividends | +87.9% | +141.3% | +87.9% | +308.2% | +75.9% |
| 5-Year ReturnCumulative with dividends | +55.7% | +182.8% | +159.4% | +436.7% | +59.5% |
| 10-Year ReturnCumulative with dividends | +21.0% | +608.7% | +410.7% | +576.7% | +206.6% |
| CAGR (3Y)Annualised 3-year return | +23.4% | +34.1% | +23.4% | +59.8% | +20.7% |
Risk & Volatility
Evenly matched — HUBB and NVT each lead in 1 of 2 comparable metrics.
Risk & Volatility
HUBB is the less volatile stock with a 1.38 beta — it tends to amplify market swings less than NVT's 1.68 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NVT currently trades 95.5% from its 52-week high vs AYI's 77.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.38x | 1.45x | 1.32x | 1.67x | 1.57x |
| 52-Week HighHighest price in past year | $380.17 | $435.43 | $565.50 | $174.50 | $165.15 |
| 52-Week LowLowest price in past year | $250.05 | $296.93 | $349.40 | $59.73 | $108.37 |
| % of 52W HighCurrent price vs 52-week peak | +77.7% | +91.7% | +87.2% | +95.5% | +85.4% |
| RSI (14)Momentum oscillator 0–100 | 58.3 | 59.8 | 41.2 | 82.3 | 61.3 |
| Avg Volume (50D)Average daily shares traded | 444K | 2.5M | 546K | 2.3M | 2.8M |
Analyst Outlook
EMR leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: AYI as "Hold", ETN as "Buy", HUBB as "Hold", NVT as "Buy", EMR as "Buy". Consensus price targets imply 32.9% upside for AYI (target: $393) vs -0.4% for ETN (target: $398). For income investors, EMR offers the higher dividend yield at 1.49% vs AYI's 0.22%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Hold | Buy | Buy |
| Price TargetConsensus 12-month target | $392.50 | $397.50 | $545.43 | $180.29 | $161.31 |
| # AnalystsCovering analysts | 33 | 39 | 17 | 19 | 41 |
| Dividend YieldAnnual dividend ÷ price | +0.2% | +1.0% | +1.1% | +0.5% | +1.5% |
| Dividend StreakConsecutive years of raises | 2 | 24 | 12 | 2 | 37 |
| Dividend / ShareAnnual DPS | $0.65 | $4.17 | $5.35 | $0.79 | $2.10 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.3% | +1.2% | +0.9% | +0.9% | +1.6% |
EMR leads in 2 of 6 categories (Income & Cash Flow, Analyst Outlook). AYI leads in 1 (Valuation Metrics). 1 tied.
AYI vs ETN vs HUBB vs NVT vs EMR: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is AYI or ETN or HUBB or NVT or EMR a better buy right now?
For growth investors, nVent Electric plc (NVT) is the stronger pick with 29.
5% revenue growth year-over-year, versus 3. 0% for Emerson Electric Co. (EMR). Acuity Brands, Inc. (AYI) offers the better valuation at 23. 6x trailing P/E (15. 0x forward), making it the more compelling value choice. Analysts rate Eaton Corporation plc (ETN) a "Buy" — based on 39 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — AYI or ETN or HUBB or NVT or EMR?
On trailing P/E, Acuity Brands, Inc.
(AYI) is the cheapest at 23. 6x versus nVent Electric plc at 38. 7x. On forward P/E, Acuity Brands, Inc. is actually cheaper at 15. 0x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Acuity Brands, Inc. wins at 1. 01x versus Emerson Electric Co. 's 4. 80x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — AYI or ETN or HUBB or NVT or EMR?
Over the past 5 years, nVent Electric plc (NVT) delivered a total return of +436.
7%, compared to +55. 7% for Acuity Brands, Inc. (AYI). Over 10 years, the gap is even starker: ETN returned +614. 3% versus AYI's +20. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — AYI or ETN or HUBB or NVT or EMR?
By beta (market sensitivity over 5 years), Hubbell Incorporated (HUBB) is the lower-risk stock at 1.
32β versus nVent Electric plc's 1. 67β — meaning NVT is approximately 27% more volatile than HUBB relative to the S&P 500. On balance sheet safety, Acuity Brands, Inc. (AYI) carries a lower debt/equity ratio of 37% versus 68% for Emerson Electric Co. — giving it more financial flexibility in a downturn.
05Which is growing faster — AYI or ETN or HUBB or NVT or EMR?
By revenue growth (latest reported year), nVent Electric plc (NVT) is pulling ahead at 29.
5% versus 3. 0% for Emerson Electric Co. (EMR). On earnings-per-share growth, the picture is similar: nVent Electric plc grew EPS 118. 8% year-over-year, compared to -6. 8% for Acuity Brands, Inc.. Over a 3-year CAGR, NVT leads at 19. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — AYI or ETN or HUBB or NVT or EMR?
nVent Electric plc (NVT) is the more profitable company, earning 18.
2% net margin versus 9. 1% for Acuity Brands, Inc. — meaning it keeps 18. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HUBB leads at 20. 8% versus 13. 7% for AYI. At the gross margin level — before operating expenses — EMR leads at 52. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is AYI or ETN or HUBB or NVT or EMR more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Acuity Brands, Inc. (AYI) is the more undervalued stock at a PEG of 1. 01x versus Emerson Electric Co. 's 4. 80x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Acuity Brands, Inc. (AYI) trades at 15. 0x forward P/E versus 37. 2x for nVent Electric plc — 22. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for AYI: 32. 9% to $392. 50.
08Which pays a better dividend — AYI or ETN or HUBB or NVT or EMR?
All stocks in this comparison pay dividends.
Emerson Electric Co. (EMR) offers the highest yield at 1. 5%, versus 0. 2% for Acuity Brands, Inc. (AYI).
09Is AYI or ETN or HUBB or NVT or EMR better for a retirement portfolio?
For long-horizon retirement investors, Eaton Corporation plc (ETN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (1.
0% yield, +614. 3% 10Y return). Both have compounded well over 10 years (ETN: +614. 3%, AYI: +20. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between AYI and ETN and HUBB and NVT and EMR?
Both stocks operate in the Industrials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: AYI is a small-cap quality compounder stock; ETN is a mid-cap quality compounder stock; HUBB is a mid-cap quality compounder stock; NVT is a mid-cap high-growth stock; EMR is a mid-cap quality compounder stock. ETN, HUBB, EMR pay a dividend while AYI, NVT do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.